GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GTBP | AZN | AMGN | GILD | VRTX |
| Company | GT Biopharma Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.8650 | 92.53 | 333.65 | 125.52 | 462.67 |
| High | 0.8700 | 92.91 | 333.98 | 125.77 | 463.65 |
| Low | 0.7821 | 92.18 | 330.85 | 124.18 | 460.86 |
| Latest | 0.8324 | 92.90 | 332.93 | 124.70 | 462.90 |
| Change | -0.0126 | +0.45 | -1.03 | -0.97 | -0.09 |
| % Change | -1.49% | +0.49% | -0.31% | -0.77% | -0.02% |
| Volume | 1,954,600 | 1,669,300 | 792,500 | 2,073,800 | 388,000 |
| 20-Day Average Volume | 1,632,485 | 5,390,480 | 3,033,295 | 6,946,210 | 1,375,770 |
| Previous Close | 0.8450 | 92.45 | 333.96 | 125.67 | 462.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7120 | 91.05 | 329.10 | 122.69 | 449.96 |
| 20-Day Raw Stochastic | 87.00% | 94.76% | 60.44% | 67.81% | 96.24% |
| 20-Day Relative Strength | 56.68 | 61.35 | 56.54 | 54.45 | 61.87 |
| Weighted Alpha | -77.99 | +43.67 | +27.40 | +31.03 | +14.16 |
| Today's Opinion | 40% Sell | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Previous Opinion | 40% Sell | 100% Buy | 96% Buy | 96% Buy | 72% Buy |
| Last Month's Opinion | 64% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.30% since 12/18/25 | +2.53% since 12/18/25 | +2.62% since 12/18/25 | +2.66% since 12/18/25 | +3.47% since 12/18/25 |
| Low | 0.7120 on 12/19/25 | 90.36 on 12/19/25 | 324.73 on 12/19/25 | 121.00 on 12/19/25 | 445.51 on 12/19/25 |
| High | 0.8700 on 12/26/25 | 93.10 on 12/23/25 | 334.38 on 12/24/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 1-Month | |||||
| %Chg | +3.82% since 11/26/25 | -0.45% since 11/26/25 | -3.38% since 11/26/25 | -2.20% since 11/26/25 | +7.11% since 11/26/25 |
| Low | 0.5808 on 12/03/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 423.45 on 12/01/25 |
| High | 0.8700 on 12/26/25 | 93.10 on 12/23/25 | 346.38 on 12/03/25 | 127.80 on 11/28/25 | 464.44 on 12/24/25 |
| 3-Month | |||||
| %Chg | +8.39% since 09/26/25 | +25.95% since 09/26/25 | +21.96% since 09/26/25 | +11.24% since 09/26/25 | +20.00% since 09/26/25 |
| Low | 0.5400 on 11/07/25 | 73.68 on 09/29/25 | 270.67 on 09/29/25 | 108.46 on 10/02/25 | 384.39 on 09/29/25 |
| High | 1.3700 on 10/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 464.44 on 12/24/25 |
| 6-Month | |||||
| %Chg | -78.09% since 06/26/25 | +32.58% since 06/26/25 | +19.28% since 06/26/25 | +15.87% since 06/26/25 | +4.40% since 06/26/25 |
| Low | 0.5400 on 11/07/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 106.84 on 06/27/25 | 362.50 on 08/11/25 |
| High | 3.8500 on 06/27/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,853 | 288,124,864 | 179,276,480 | 154,712,800 | 117,446,520 |
| Shares Outstanding, K | 10,636 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -13,160,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -3,110,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.52 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.83 on 11/14/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 02/20/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.23 | 15.27 | 15.34 | 30.24 |